Skip to main content
Circa Group AS logo

Circa Group AS — Investor Relations & Filings

Ticker · CIRCA ISIN · NO0010917594 LEI · 549300TYMT7PQV920R92 OL Manufacturing
Open in API
Filings indexed 376 across all filing types
Latest filing 2023-05-25 AGM Information
Country NO Norway
Listing OL CIRCA

About Circa Group AS

https://circa-group.com/

Circa Group AS is a renewable chemicals company that develops and commercializes bio-based products. It utilizes a proprietary thermochemical process, Furacell™, to convert non-food, waste cellulosic biomass into advanced biochemicals. The company's portfolio is centered on the platform chemical levoglucosenone (LGO) and its derivatives, most notably the bio-based solvent Cyrene™. Cyrene™ is designed as a safer, more sustainable alternative to traditional, fossil-derived polar aprotic solvents like NMP. Circa aims to produce these biochemicals at an industrial scale, serving various markets, including pharmaceuticals, agrochemicals, and specialty polymers, that are transitioning to greener chemistry. The company is scaling up its manufacturing capabilities through its ReSolute plant project.

Recent filings

Filing Released Lang Actions
Circa Group AS - Minutes from Annual General Meeting
AGM Information Classification · 100% confidence The document explicitly states "Annual General Meeting Circa Group AS" at the beginning and details the agenda items, which include the "Opening of General Meeting," approval of annual accounts, election of board members, and amendments to articles of association. The content directly reflects the proceedings and resolutions typically found in materials presented or documented during an Annual General Meeting (AGM). This aligns perfectly with the AGM Information (AGM-R) definition.
2023-05-25 English
Circa Group AS - Minutes from Annual General Meeting
AGM Information Classification · 98% confidence The document is explicitly titled 'Circa Group AS - Minutes from Annual General Meeting' and discusses the proceedings of the Annual General Meeting held on May 25, 2023. The content summarizes that agenda items were adopted and mentions that the minutes, attendance list, voting results, and the presentation are attached. Since the document is the minutes/summary of the AGM proceedings, it directly relates to the AGM event. The most appropriate classification is AGM Information (AGM-R). Although it mentions attachments, the primary content is the record of the meeting itself, not just an announcement of a report release.
2023-05-25 English
Q1 2023 RESULTS HIGHLIGHT LARGEST SALES OF CYRENE™ AND PROGRESS ON PERMANENT PERMIT FOR RESOLUTE™ PLANT
Investor Presentation Classification · 99% confidence The document is explicitly titled "Q1 2023 Results *Presentation*" and contains slides detailing financial performance (Income statement, Balance sheet for Q1 23 vs Q1 22), commercial developments, product progress (FC5, ReSolute, FC6), and an outlook. This structure is characteristic of an Investor Presentation (IP) used to communicate periodic results, rather than the formal, comprehensive regulatory report (like 10-K or IR) or the initial press release (ER). Since the document is a detailed presentation summarizing quarterly performance, Investor Presentation (IP) is the most appropriate classification.
2023-05-11 English
Q1 2023 RESULTS HIGHLIGHT LARGEST SALES OF CYRENE™ AND PROGRESS ON PERMANENT PERMIT FOR RESOLUTE™ PLANT
Earnings Release Classification · 100% confidence The document is explicitly titled 'PRESS RELEASE' and announces the company's 'Q1 2023 RESULTS HIGHLIGHTS'. It provides key operational and sales updates for the first quarter (Q1 2023) and directs the reader to access the 'complete Q1 report' via a link. This structure—a brief press release summarizing key figures and operational milestones for a specific period, often accompanied by a call/webinar announcement, but not containing the full, detailed financial statements—is characteristic of an Earnings Release (ER). It is not the comprehensive Interim Report (IR) itself, nor is it a full Annual Report (10-K). Given the short length (4320 chars) and the explicit reference to accessing the 'complete Q1 report', it fits the definition of an Earnings Release (ER) best, which is the initial announcement of periodical financial results. Q1 2023
2023-05-11 English
Q1 2023 RESULTS HIGHLIGHT LARGEST SALES OF CYRENE™ AND PROGRESS ON PERMANENT PERMIT FOR RESOLUTE™ PLANT
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first quarter of 2023 (Q1 2023) for Circa Group AS. It includes a 'Report of the Board of Directors', detailed 'Interim financial statements' (Consolidated income statement, balance sheet, and statement of changes in equity), and notes on financial performance. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2023
2023-05-11 English
Q1 2023 RESULTS HIGHLIGHT LARGEST SALES OF CYRENE™ AND PROGRESS ON PERMANENT PERMIT FOR RESOLUTE™ PLANT
Earnings Release Classification · 98% confidence The document explicitly states it announces the 'first quarter results today' for Circa Group AS and provides key highlights regarding sales (Cyrene™) and operational progress (ReSolute™ plant). It concludes by directing the reader to access the 'complete Q1 report' via a link and invites participation in a 'Q1 results webinar'. Since this is a short announcement summarizing the period's performance and pointing to the full report, it fits the definition of an Earnings Release (ER). It is not the comprehensive report itself (which would be an IR), nor is it a general announcement about publishing a report (RPA), as it contains substantive results highlights. Q1 2023
2023-05-11 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.